Recognition and Treatment of Adrenal Insufficiency Secondary to Abiraterone: A Case Report and Literature Review
Sign Up to like & getrecommendations! Published in 2019 at "Oncology"
DOI: 10.1159/000501640
Abstract: Objective: Abiraterone is a relatively noncytotoxic drug approved by the US Food and Drug Administration in 2011 for the treatment of metastatic prostate cancer (MPC). As an inhibitor of 17α-hydroxylase and C17,20-lyase (CYP17), abiraterone blocks… read more here.
Keywords: recognition treatment; abiraterone; adrenal insufficiency; treatment adrenal ... See more keywords
Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2019.00732
Abstract: Purpose: This study aimed to describe our institutional experience in the use of stereotactic body radiation therapy (SBRT) for the management of adrenal gland metastases from multiple primary cancers. Materials and Methods: We retrospectively reviewed… read more here.
Keywords: adrenal gland; treatment; stereotactic body; gland metastases ... See more keywords